SCHEMBL2923170

SCHEMBL2923170

C=CC[Ce]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9244246 0.95
Benzene SCHEMBL3704849 0.87 TSHR (0.31)
SCHEMBL28987001 0.78
SCHEMBL1235562 0.67
Hydrochloric Acid SCHEMBL10323675 0.63
SCHEMBL11082318 0.63
SCHEMBL23732 0.59
SCHEMBL8852489 0.59 TSHR (0.54)
SCHEMBL1328 0.59
SCHEMBL23546 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1729772-B1 HETEROARYL PIPERIDINE GLYCINE TRANSPORTER INHIBITORS MERCK SHARP & DOHME (US) 2016-12-07 EP disclosed
CN-103534471-B Device for dispensing an additive FILTRAUTO (FR) 2016-06-01 CN disclosed
CN-103534471-A Device for dispensing an additive FILTRAUTO SA 2014-01-22 CN disclosed
CN-101084215-B Piperidine and azetidine derivatives as GLYT1 inhibitors MERCK SHARP & DOHME 2013-10-30 CN disclosed
CN-101910179-B Glucocorticoid receptor modulator and use method LILLY CO ELI 2013-06-19 CN disclosed
EP-1893566-B1 CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA MERCK SHARP & DOHME (GB) 2013-02-13 EP disclosed
EP-1891002-B1 CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA MERCK SHARP & DOHME (GB) 2012-05-30 EP disclosed
CN-1933836-B Heteroaryl piperidine glycine transporter inhibitors MERCK & CO INC 2011-08-17 CN disclosed
US-7851638-B2 Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia MERCK SHARP & DOHME LIMITED (GB) 2010-12-14 US disclosed
CN-101910179-A (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid LILLY CO ELI 2010-12-08 CN disclosed
WO-1995016672-A1 VITAMIN D AMINE AND AMIDE DERIVATIVES HOLMES, MICHAEL, JOHN (GB) 1995-06-22 WO disclosed
US-5369125-A Cholesterol-lowering agents MERCK & CO., INC. (US) 1994-11-29 US disclosed
EP-0337167-B1 4-Aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof DU PONT MERCK PHARMA (US) 1994-08-03 EP disclosed
WO-1994002134-A1 CHOLESTEROL-LOWERING AGENTS MERCK & CO., INC. (US) 1994-02-03 WO disclosed
WO-1993021169-A1 BENZOTHIAZOLE-SUBSTITUTED BENZYL ALCOHOLS AS LEUKOTRIENE ANTAGONISTS MERCK FROSST CANADA INC. (CA) 1993-10-28 WO disclosed
WO-1993021168-A1 THIAZOLE-SUBSTITUTED BENZYL ALCOHOLS AS LEUKOTRIENE ANTAGONISTS MERCK FROSST CANADA INC. (CA) 1993-10-28 WO disclosed
US-5086063-A Analgesics, antidepressants, anorexigenic agents DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-02-04 US disclosed
CN-1054424-A In a unique multi-function rotating reactor, implement the method and the spendable agitator of magnetic drive, particularly spendable agitator of magnetic drive in this reactor of the solid ingredient of synthetic Ziegler-type catalytic solid or this class catalytic solid ELF AQUITAINE (FR) 1991-09-11 CN disclosed
US-5019650-A 4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-28 US disclosed
EP-0337167-A1 4-Aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1989-10-18 EP disclosed